Xalkori
NDC 0069-1500, CRIZOTINIB, capsule, coated pellets, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-1500
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217581
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CRIZOTINIB150 mg/1
Pharmacologic classes
Cytochrome P450 2B6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Organic Cation Transporter 1 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Receptor Tyrosine Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-1500-60 | 00069150060 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0069-1500-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2a51b0de-47d6-455e-a94c-d2c737b04ff7
Use it
Look up 0069-1500 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-1500. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.